Fund moves
28 tracked managers disclosed the same change for Q4 2024. From a 13F filed Jan 15, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Dec 16, 2024 · Filed Dec 17, 2024
United Therapeutics's PRESIDENT AND COO sold $36K of United Therapeutics shares. The filing says it was made under a pre-arranged trading plan.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market sale
Code S — open-market or private sale
~$36,325
Shares × reported transaction price
47 days after results of Oct 30, 2024, 72 days before results of Feb 26, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.8% | +2.6% | −0.7% |
| 30 days | +0.4% | +1.9% | −1.5% |
| 90 days | −12.2% | −4.3% | −7.8% |
| 180 days | −19.3% | +2.8% | −22.1% |
| 365 days | +41.8% | +15.4% | +26.4% |
Past results only. Not a forecast.
Fund moves
28 tracked managers disclosed the same change for Q4 2024. From a 13F filed Jan 15, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Michael Benkowitz (PRESIDENT AND COO) sold ~$71K of United Therapeutics
Planned saleMichael Benkowitz (PRESIDENT AND COO) sold ~$219K of United Therapeutics
Planned saleEvery dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.